Talkspace is using AI to make mini podcast episodes from patients’ therapy sessions. The “Talkcast” episodes are meant to be ...

Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal ...

Eli Lilly's RNA drug solbinsiran reduced ApoB protein levels by 14.3% in Phase 2 cholesterol trial, competing with ...

Sanofi hires former GSK development head Chris Corsico as global R&D head, replacing Dietmar Berger who left for Gilead. Move ...

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring ...

The FDA overstepped its authority when it issued a rule last May to bring laboratory-developed tests under the agency’s ...

Heart gene therapy maker Tenaya Therapeutics is laying off 30% to 40% of its staff by the end of the year, the company’s CEO ...

As­traZeneca has great am­bi­tions for its mid-stage oral cho­les­terol drug, be­liev­ing that it could reach peak sales of ...

Vaxcyte’s stock price dropped by 50% on Monday after the company reported new Phase 2 data from a study evaluating an ...

Corcept Therapeutics’ oral glucocorticoid receptor antagonist has improved survival outcomes in a late-stage test in patients ...

Phase 2 results on Eli Lilly’s experimental heart disease drug showed it could be dosed far less frequently than competing ...

FDA biologics chief Peter Marks resigns over vaccine dispute with HHS Secretary RFK Jr., causing biotech stocks to drop.